The Trump administration pulled one of its key proposals to lower drug prices by eliminating industry rebates in Medicare — a policy its top health official had touted as one of the most significant changes to curb medicine costs for consumers.
The rule is the second major drug pricing effort to collapse this week, complicating the administration's efforts to make lowering prescription costs a key 2020 presidential campaign issue.
